Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple coagulation factors comprise a group of proteins in blood plasma essential for hemostasis and blood clot formation. These factors participate in the coagulation cascade, preventing excessive bleeding and avoiding unnecessary clot formation. Dysregulation can lead to bleeding disorders, thrombosis, and involvement in inflammation and immune responses. Drugs like warfarin target vitamin K metabolism, impacting the functionality of several coagulation factors.
Vitamin K antagonism, inhibition of coagulation factor activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Coagulation Factors.